artesunate plus amodiaquine

DRUG3 trials

Sponsors

Bernhard Nocht Institute for Tropical Medicine, EDCTP, National Malarial and Vector Control

Conditions

MalariaMalaria, Falciparum

Phase 4

Randomized Trial on Effectiveness of ACTs in Ghana

TerminatedNCT00374205

Bernhard Nocht Institute for Tropical MedicineMalaria, Falciparum

Start: 2006-09-30End: 2007-10-31Updated: 2007-11-27

Unknown Phase

Drug therapeutic efficacy testing

Active, not recruitingPACTR201510001189370

National Malarial and Vector ControlMalaria

Start: 2009-05-03Updated: 2026-09-14

Validation of New Biomarkers for Monitoring P. falciparum Reduced susceptibility/Tolerance or Resistance to Artemisinin Derivatives and Partner Drugs

Active, not recruitingPACTR201508001191898

Start: 2009-01-09Updated: 2026-09-14

Related Papers

Declining responsiveness of childhood Plasmodium falciparum infections to artemisinin-based combination treatments ten years following deployment as first-line antimalarials in Nigeria

Infectious Diseases of Poverty2019-08-0619 citations

Therapeutic efficacy and effects of artemisinin-based combination treatments on uncomplicated Plasmodium falciparum malaria -associated anaemia in Nigerian children during seven years of adoption as first-line treatments.

2017-02-0712 citations

Early rising asexual parasitaemia in Nigerian children following a first dose of artemisinin-based combination treatments of falciparum malaria

BMC Infectious Diseases2017-01-317 citations

Therapeutic efficacy and effects of artesunate-amodiaquine and artemether-lumefantrine on malaria-associated anaemia in Nigerian children aged two years and under.

2016-07-065 citations

Clinical illness and outcomes in Nigerian children with late-appearing anaemia after artemisinin-based combination treatments of uncomplicated falciparum malaria.

2016-06-0111 citations

Temporal changes in haematocrit following artemisinin-based combination treatments of uncomplicated falciparum malaria in children.

2015-10-2610 citations